![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25517-25524, September 3, 1999
From the Department of Molecular Biology and Biochemistry, Osaka University Medical School, Suita 565-0871, Japan
| |
ABSTRACT |
|---|
|
|
|---|
Rab11 small G protein has been implicated in
vesicle recycling, but its upstream regulators or downstream targets
have not yet been identified. We isolated here a downstream target of
Rab11, named rabphilin-11, from bovine brain. Moreover, we isolated
from a rat brain cDNA library its cDNA, which encoded a protein
with a Mr of 100,946 and 908 amino acids (aa).
Rabphilin-11 bound GTP-Rab11 more preferentially than GDP-Rab11 at the
N-terminal region and was specific for Rab11 and inactive for other Rab
and Rho small G proteins. Both GTP-Rab11 and rabphilin-11 were
colocalized at perinuclear regions, presumably the Golgi complex and
recycling endosomes, in Madin-Darby canine kidney cells. In HeLa cells
cultured on fibronectin, both the proteins were localized not only at
perinuclear regions but also along microtubules, which were oriented
toward membrane lamellipodia. Treatment of HeLa cells with nocodazole caused disruption of microtubules and dispersion of GTP-Rab11 and
rabphilin-11. Overexpression of the C-terminal fragment of rabphilin-11
(aa 607-730), lacking the GTP-Rab11 binding domain, in HeLa cells
reduced accumulation of transferrin at perinuclear regions and cell
migration. Rabphilin-11 turned out to be a rat counterpart of recently
reported bovine Rab11BP. These results indicate that rabphilin-11 is a
downstream target of Rab11 which is involved in vesicle recycling.
The Rab family small G proteins, consisting of more than 30 members, regulate intracellular vesicle trafficking, including exocytosis, endocytosis, and recycling (for reviews, see Refs, 1-4).
We purified a small G protein with a Mr of about
24,000 from the microsome-Golgi fraction of rat liver in 1990 (5) and
cloned its cDNA in 1991 (6). The sequence analysis revealed that
this small G protein is a rat counterpart of canine Rab11, which had
been cloned from a MDCK1 cell
cDNA library by Chavrier et al. (7) in 1990. Rab11 is ubiquitously expressed but particularly enriched in tissues with active
vesicle trafficking (6, 7). Rab11 has subsequently been shown to be
localized at sorting endosomes, recycling endosomes, the
trans-Golgi network membranes, and the post-Golgi secretory vesicles, and to be implicated in vesicle recycling (8-11). However, the mode of action of Rab11 in vesicle recycling has not yet been clarified.
The Rab family small G proteins have two interconvertible forms, the
GDP-bound inactive and GTP-bound active forms (3, 4). The conversion of
the GDP-bound form to the GTP-bound form is regulated by two types of
upstream regulators, GEPs and GDIs. The reverse conversion is regulated
by GTPase-activating proteins. Each Rab family member appears to have
its specific GEP and GTPase-activating protein, whereas GDIs are active
on all the Rab family members. The GTP-bound form binds to downstream
target(s) that exerts its function. Of the many Rab family members, the
downstream targets of Rab3, -5, -6, -8, and -9, named rabphilin-3 (12,
13) and rim (14), rabaptin-5 (15) and EEA1 (16, 17), rabkinesin-6 (18),
rab8ip (19), and p40 (20), respectively, have thus far been identified
and characterized. However, neither the upstream regulators nor the
downstream targets of Rab11 have been identified.
We isolated and characterized here a downstream target of Rab11. We
named this protein rabphilin-11, because we previously isolated and
characterized a downstream target of Rab3 and named it rabphilin-3
(philin for the Greek word for friend) (13).
[35S]GTP Purification and Molecular Cloning of Rabphilin-11--
All the
following procedures were done at 4 °C. Bovine brains (250 g wet
weight) were homogenized with a solution (300 ml) containing 20 mM Tris/HCl at pH 7.5, 2 mM EDTA, 0.32 M sucrose, and a protease inhibitor mixture (10 µM p-amidinophenylmethanesulfonyl fluoride, 20 µg/ml leupeptin, and 1 µg/ml pepstatin A). The homogenate was
centrifuged at 100,000 × g for 1 h. The
supernatant was stored at Expression and Purification of Recombinant
Rabphilin-11--
Prokaryotic and eukaryotic expression vectors were
constructed in pMALC2 (New England Biolabs), pGEX (Amersham Pharmacia
Biotech), pRSET (Invitrogen), and pEGFP (CLONTECH)
by use of standard molecular biological methods. Full-length
rabphilin-11 was constructed in the pRSET vector. Full-length
His6-rabphilin-11 was produced in vitro and labeled with
[35S]methionine by use of the TNT T7-coupled reticulocyte
lysate system (Promega). The truncated mutants of rabphilin-11 were
constructed in the pMALC2 and pGEX vectors as follows:
pMALC2-rabphilin-11-1, aa 1-631; pMALC2-rabphilin-11-2, aa 632-908;
pMALC2-rabphilin-11-3, aa 53-301; and pGEX-rabphilin-11-3, aa
53-301. The full-length and truncated mutants of rabphilin-11 were
constructed in the pEGFP vector; pEGFP-rabphilin-11, full length;
pEGFP-rabphilin-11-1, aa 1-631; and pEGFP-rabphilin-11-4, aa
607-730.
Cell Culture and Transfection--
MDCK cells were supplied by
Dr. W. Birchmeier (Max-Delbruck-Center for Molecular Medicine, Berlin,
Germany). HeLa cells were supplied by Dr. S. Orita (Discovery Research
Laboratory, Shionogi & Co. LTD, Osaka, Japan). KB cells were supplied
by Dr. Y. Miyata (Tokyo Metropolitan Institute of Medical Science,
Tokyo, Japan). MDCK cells were cultured at 37 °C in a humidified
atmosphere of 10% CO2 and 90% air in DMEM containing 10%
FCS (Life Technologies, Inc.), 100 units/ml penicillin, and 100 µg/ml
streptomycin. HeLa cells and KB cells were cultured at 37 °C in a
humidified atmosphere of 5% CO2 and 95% air in the same
medium. Where indicated, HeLa cells were cultured on the dishes
precoated with fibronectin. Fibronectin-coated dishes were prepared by
incubation of non-treated dishes with 10 µg/ml human plasma
fibronectin (Sigma) at 4 °C overnight, followed by incubation with
1% BSA/PBS at 37 °C for 1 h. HeLa cells, which had been
cultured on non-treated dishes, were trypsinized and washed once in
serum-free DMEM. The cells were resuspended in serum-free DMEM (2 × 104 cells/ml), placed on fibronectin-coated dishes, and
used for experiments.
Transient transfection of pEGFP-rabphilin-11 into MDCK cells or HeLa
cells was performed by use of Superfect reagent (Qiagen). MDCK cells
stably expressing a Myc-tagged dominant active mutant of Rab11
(sMDCK-Myc-Rab11Q70L cells) or a Myc-tagged dominant negative mutant of
Rab11 (sMDCK-Myc-Rab11S25N cells) were established (23). Stable
transfection of pSR Antibodies and Immunofluorescence Staining--
A rabbit
polyclonal antibody against rabphilin-11 was raised against
GST-rabphilin-11-3 (aa 53-301). The antiserum was affinity purified
with MBP-rabphilin-11-3 (aa 53-301) covalently coupled to
CNBr-activated Sepharose (Amersham Pharmacia Biotech). Hybridoma cells
expressing the mouse monoclonal anti-Myc antibody (9E10) were purchased
from American Type Culture Collection (Rockville, MD). An anti-tubulin
Immunofluorescence microscopy was performed as described (23). Briefly,
the cells used here were fixed in 3.7% formaldehyde/PBS for 20 min.
The fixed cells were permeabilized with 0.2% Triton X-100/PBS for 10 min. After being soaked in 10% FCS/PBS for 1 h, the cells were
treated with the first antibody in 10% FCS/PBS for 1 h. The cells
were then washed with PBS three times, followed by incubation with the
second antibody in 10% FCS/PBS for 1 h. After being washed with
PBS three times, the cells were examined by use of a ECLIPSE E800
immunofluorescence microscope (Nikon, Tokyo, Japan). Where indicated,
an LSM 410 confocal laser scanning microscope (Carl Zeiss, Oberkochen,
Germany) was used.
Assay for Internalization of Transferrin--
Assay for
internalization of transferrin in HeLa cells or KB cells was performed
as described (24). Briefly, HeLa cells or KB cells were transfected
with the plasmids encoding the indicated proteins by use of Superfect
reagent (Qiagen). After 18 h, the cells were incubated at 37 °C
for 1 h with serum-free DMEM, followed by incubation at 37 °C
for 1 h with serum-free DMEM containing 0.1 mg/ml Texas
Red-conjugated transferrin (Molecular Probes, Inc.). The cells were
then immunostained and analyzed.
Phagokinetic Track Motility Assay--
Uniform carpet of gold
particles was prepared on glass coverslips (Matsunami Glass) as
described (25, 26). The colloidal gold-coated coverslips were placed in
35-mm non-treated dishes, and the coverslips were coated with 10 µg/ml fibronectin by incubation at 4 °C overnight. HeLa cells
suspended in DMEM (2 × 104 cells/ml) were added to
each gold-coated coverslip and incubated. After 6 h, the cells
expressing each GFP-tagged protein were visualized on an inverted
DIAPHOT 300 microscope (Nikon, Tokyo, Japan), and cell migration was
analyzed by measuring the areas free of gold particles around a single
cell. The statistical analysis of migration was analyzed with analysis
of variance, and significance was determined by paired t test.
Other Procedures--
SDS-PAGE (8% polyacrylamide gel) was
performed as described (27). Protein concentrations were determined
with BSA as a reference protein (28).
Identification, Partial Purification, and Characterization of
Rabphilin-11--
We identified a band of
[35S]GTP Molecular Cloning and Determination of the Nucleotide and Deduced
Amino Acid Sequences of Rabphilin-11--
We determined the partial aa
sequences of p140. The aa sequences of p140 were not found in the
current protein data base. On the basis of this information, we
isolated a p140 cDNA from a rat brain cDNA library and
determined its nucleotide sequence. The encoded protein consisted of
908 aa and showed a calculated Mr of 100,946 (GenBankTM accession number AF130121) (Fig.
3A). It included all the partial aa sequences except 6 aa. The slight difference of the aa
sequences might be due to the differences in species.
The calculated Mr value was less than that
estimated by SDS-PAGE. To confirm whether this clone contained the
full-length cDNA of p140, we constructed the pRSET vector with this
cDNA and expressed the protein in vitro and labeled with
[35S]methionine by use of the TNT T7-coupled reticulocyte
lysate system. The in vitro translated product showed a
motility similar to that of native p140 on SDS-PAGE (Fig.
3Ba). Therefore, we concluded that this clone encoded the
full-length cDNA of p140.
After we had submitted this original manuscript, Zeng et al.
(29) isolated a putative target of Rab11 from bovine brain by the
method similar to ours, determined its nucleotide and deduced aa
sequences, and named it Rab11BP (Rab11-binding protein). All the
partial aa sequences of our p140 were included in the deduced aa
sequence of Rab11BP. Comparison of deduced aa sequences of our rat and
their bovine proteins revealed that they showed 85% identity over the
entire sequences (data not shown). This aa difference might be due to
the difference of species, and our rabphilin-11 is most likely to be a
rat counterpart of bovine Rab11BP.
Characterization of Recombinant Rabphilin-11--
By use of
recombinant rat rabphilin-11, we found that
[35S]GTP Tissue Distribution of Rabphilin-11--
Rab11 is expressed in
various tissues but abundant in brain, lung, adrenal gland, kidney,
pancreas, and testis (6, 30). Northern blot analysis indicated that
rabphilin-11 was also expressed in various rat tissues examined (Fig.
4). Of various cell lines, rabphilin-11
was abundant in MDCK cells, HeLa cells, and PC12 cells (data not
shown).
Colocalization of Rabphilin-11 with GTP-Rab11 at Perinuclear
Regions--
Subcellular localization analysis showed that both
expressed GDP-Rab11 (a Myc-tagged dominant negative mutant of Rab11,
Myc-Rab11S25N), and GFP-tagged full-length rabphilin-11 were found in
the cytoplasm in MDCK cells stably expressing Myc-Rab11S25N
(sMDCK-Myc-Rab11S25N cells) (Fig.
5A, a and b),
whereas both expressed GTP-Rab11 (a Myc-tagged dominant active
mutant of Rab11, Myc-Rab11Q70L), and GFP-tagged full-length
rabphilin-11 were colocalized at perinuclear regions (Fig. 5B,
a and b). When endogenous rabphilin-11 was stained in
MDCK cells stably expressing Myc-Rab11Q70L (sMDCK-Myc-Rab11Q70L cells)
and sMDCK-Myc-Rab11S25N cells, essentially the same results were
obtained (data not shown). These results suggest that rabphilin-11 binds GTP-Rab11 not only in a cell-free system but also in intact cells
and that they are colocalized at perinuclear regions, which presumably
correspond to the Golgi complex and recycling endosomes.
Colocalization of Rabphilin-11 with GTP-Rab11 along
Microtubules--
It has been shown that microtubules are oriented
toward lamellipodia (31) and that microtubules are involved in vesicle recycling (32-34). We examined the localization of a Myc-tagged dominant active mutant of Rab11 (Myc-Rab11Q70L) and rabphilin-11 in
HeLa cells cultured on fibronectin. The HeLa cells cultured on
fibronectin showed well developed lamellipodia toward which microtubules were oriented (Fig. 6,
A and B). Both Myc-Rab11Q70L and rabphilin-11
were localized not only at perinuclear regions but also along these
microtubules (Fig. 6A). When the GFP-tagged N-terminal
fragment of rabphilin-11 (GFP-rabphilin-11-1, aa 1-631), including
the GTP-Rab11 binding domain, was expressed in HeLa cells cultured on
fibronectin, it was localized both at perinuclear regions and along
microtubules, whereas when the GFP-tagged C-terminal fragment of
rabphilin-11 (GFP-rabphilin-11-4, aa 607-730), lacking the GTP-Rab11
binding domain, was expressed, it was diffusely localized in the
cytoplasm (Fig. 6B). These results suggest that the
N-terminal region of rabphilin-11 is responsible for its localization at perinuclear regions and along microtubules. Treatment of these cells
with nocodazole, a microtubule-disrupting agent, caused disruption of
microtubules and dispersion of both Myc-Rab11Q70L and rabphilin-11
(Fig. 6C). These results have provided additional evidence
that GTP-Rab11 and rabphilin-11 interact with each other in intact
cells and furthermore suggest that both the proteins are localized
presumably on the recycling vesicles at perinuclear regions and along
microtubules.
Involvement of Rabphilin-11 in Accumulation of Transferrin at
Perinuclear Regions--
We examined whether rabphilin-11 indeed
regulates vesicle recycling as described for Rab11 (9, 11).
Overexpression of a Myc-tagged dominant negative mutant of Rab11
(Myc-Rab11S25N) in HeLa cells markedly inhibited accumulation of
transferrin at perinuclear regions as compared with those in wild-type
cells (data not shown), consistent with the earlier observations (9, 11). Similarly, overexpression of the GFP-tagged C-terminal fragment of
rabphilin-11 (GFP-rabphilin-11-4, aa 607-730), lacking the GTP-Rab11
binding domain, markedly inhibited this accumulation (Fig.
7A, a and b).
However, overexpression of GFP-tagged full-length rabphilin-11 did not
affect this accumulation (Fig. 7A, c and d).
Overexpression of the GFP-tagged N-terminal fragment of rabphilin-11 (GFP-rabphilin-11-1, aa 1-631), including the GTP-Rab11 binding domain, did not affect this accumulation, either (data not shown). The
essentially similar results were obtained when the similar experiments
were done with KB cells (Fig. 7B). It is not clear to which
intracellular organellae the perinuclear regions correspond, but they
may be the Golgi complex and recycling endosomes. These results,
together with the earlier observations that Rab11 regulates vesicle
recycling (9, 11), suggest that rabphilin-11 also regulates vesicle
recycling.
Transferrin was also observed as small dots widely distributed
throughout the cytoplasm in HeLa cells and KB cells (Fig. 7). This
distribution of transferrin was not affected by overexpression of
Myc-Rab11S25N (data not shown) or the GFP-tagged C-terminal fragment of
rabphilin-11 (Fig. 7, Aa and Ba). It is not clear where these dots correspond, but they may be early endosomes. If this
is the case, Rab11 and rabphilin-11 may not be involved in vesicle
trafficking from the plasma membrane to early endosomes by endocytosis,
and this conclusion is consistent with the earlier observations for
Rab11 (9, 11).
It has been reported by Zeng et al. (29) that the N-terminal
fragment of Rab11BP (aa 1-504) inhibits the accumulation of transferrin at endosomes in TRVb cells, and our above result is apparently inconsistent with this observation. The exact reason for
this discrepancy is not known at present, but this might be due either
to different lengths of the N-terminal fragments of Rab11BP and
rabphilin-11 or to a lower expression level of the N-terminal fragment
of rabphilin-11 (aa 1-631) in our assay system than that of the
N-terminal fragment of Rab11BP (aa 1-504) in their assay system. They
did not examine the effect of the C-terminal fragment of Rab11BP, but
our results clearly indicate that the C-terminal fragment of
rabphilin-11 (aa 607-730) reduces the accumulation of transferrin at
perinuclear regions (Fig. 7, Aa and Ba), and the
expression levels of the N-terminal and C-terminal fragments were
apparently similar (data not shown). Therefore, it could be concluded
from their experiments and our experiments that the C-terminal fragment
might be more effective than the N-terminal fragment on inhibiting
vesicle recycling.
Involvement of Rabphilin-11 in Cell Migration--
It has been
shown that vesicle recycling is necessary for cell migration (35, 36).
Finally, we examined whether Rab11 and rabphilin-11 are involved in
cell migration. For this purpose, we first used MDCK cells stably
expressing a Myc-tagged dominant active mutant of Rab11
(sMDCK-Myc-Rab11Q70L cells) or MDCK cells stably expressing a
Myc-tagged dominant negative mutant of Rab11 (sMDCK-Myc-Rab11S25N
cells), and we estimated cell migration by use of the gold particle
uptake assay. Wild-type MDCK cells and sMDCK-Myc-Rab11Q70L cells
migrated to a similar extent, but sMDCK-Myc-Rab11S25N cells migrated
significantly to a lesser extent (data not shown). Because MDCK cells
stably expressing various mutants of rabphilin-11 were not available,
we transiently overexpressed GFP-tagged full-length rabphilin-11, the
GFP-tagged N-terminal fragment (GFP-rabphilin-11-1, aa 1-631), or the
GFP-tagged C-terminal fragment of rabphilin-11 (GFP-rabphilin-11-4, aa
607-730) in HeLa cells cultured on fibronectin, and we assayed their
migration. Overexpression of the C-terminal fragment, but not
full-length rabphilin-11 or the N-terminal fragment, markedly reduced
cell migration (Fig. 8). These results
suggest that both Rab11 and rabphilin-11 are involved in cell
migration. We have not examined here the overexpression of Rab11S25N in
HeLa cells, because GFP-tagged Rab11S25N was not available, but the inhibitory effect of Rab11S25N on migration of MDCK cells is consistent with the inhibitory effect of the C-terminal fragment of rabphilin-11 on migration of HeLa cells.
In this study, we have isolated and characterized a
GTP-Rab11-binding protein and named it rabphilin-11. We have concluded that rabphilin-11 is a downstream target of Rab11 that has been implicated in vesicle recycling (8-11) on the basis of the following observations: 1) it binds GTP-Rab11 more preferentially than GDP-Rab11 without stimulating the GTPase activity of Rab11; 2) it is colocalized with GTP-Rab11 at perinuclear regions in MDCK cells and HeLa cells and
also along microtubules in HeLa cells; and 3) rabphilin-11 as well as
Rab11 regulates accumulation of transferrin at perinuclear regions and
cell migration.
We have shown here that Rab11 and rabphilin-11 are colocalized at
perinuclear regions in HeLa cells and KB cells and that both the
proteins regulate the accumulation of transferrin there without
affecting its accumulation at small dots which are widely distributed
in the cytoplasm. The precise localization sites of GTP-Rab11 and
rabphilin-11 at perinuclear regions are not known, but they are likely
the Golgi complex and recycling endosomes, and the small dots in the
cytoplasm may be early endosomes. If these sites are correct, both the
proteins may regulate at least vesicle recycling from early endosomes
to recycling endosomes.
Moreover, we have shown here that Rab11 and rabphilin-11 are
colocalized along microtubules oriented toward lamellipodia. Microtubules are known to be implicated in transport from early endosomes to late endosomes and apical vesicle recycling, both of which
are inhibited by nocodazole in polarized MDCK cells (33, 34). It is not
known whether Rab11 and rabphilin-11 are involved in apical vesicle
recycling along microtubules, but the localization of Rab11 and
rabphilin-11 along microtubules oriented toward lamellipodia has raised
their possible involvement in apical vesicle recycling.
Vesicle recycling of various transmembrane proteins, including adhesion
molecules such as integrin, has been implicated in cell migration
(37-40). We have recently shown that dynamic rearrangement of focal
adhesion and stress fibers are observed during migration of MDCK cells
and that Rab GDI, a general regulator of all the Rab family members,
and at least Rab5 are involved in this rearrangement, most presumably
by regulating endocytosis and recycling of integrin (23). Consistently,
we have shown here that overexpression of a dominant negative mutant of
Rab11 (Rab11S25N) and the C-terminal fragment of rabphilin-11 (aa
607-730), lacking the GTP-Rab11 binding domain, reduce migration of
MDCK cells and HeLa cells, respectively. It remains to be clarified how
these proteins reduce cell migration, but they may reduce cell
migration by inhibiting the vesicle recycling from early endosomes to
recycling endosomes.
Of the downstream targets of the Rab family members thus far reported,
Shirataki et al. (41) and Mckiernan et al. (42) have shown that rabphilin-3, a target of Rab3, is associated with synaptic vesicles in a manner independent of GTP-Rab3A, although Stahl
et al. (43) have shown that it is associated with the vesicles in a manner dependent on GTP-Rab3A, whereas rabaptin-5, a
target of Rab5, is associated with early endosomes in a manner dependent on GTP-Rab5 (15). We have shown here that both GDP-Rab11 (a
Myc-tagged dominant negative mutant of Rab11, Myc-Rab11S25N) and
rabphilin-11 are found in the cytoplasm in MDCK cells stably expressing
Myc-Rab11S25N (sMDCK-Myc-Rab11S25N cells), whereas both GTP-Rab11 (a
Myc-tagged dominant active mutant of Rab11, Myc-Rab11Q70L) and
rabphilin-11 are colocalized at perinuclear regions in MDCK cells
stably expressing Myc-Rab11Q70L (sMDCK-Myc-Rab11Q70L cells). These
results suggest that rabphilin-11 is translocated between the cytoplasm
and the membranes of perinuclear regions coupled with the cycling of
Rab11 between the GDP-bound and GTP-bound forms.
In conclusion, rabphilin-11 is a downstream target of Rab11 that
regulates vesicle recycling. Further studies are necessary for our
understanding of the modes of activation and action of Rab11 and
rabphilin-11 in vesicle recycling.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S-GST-Rab11 Blot
Overlay--
GST-Rab11, -Rab3A, -Rab5, and -RhoA were purified from
overexpressing Escherichia coli as described (12).
[35S]GTP
S-GST-Rab11 blot overlay was done as described
(21). Briefly, purified GST-Rab11 (40 pmol) was labeled with 1.25 µM [35S]GTP
S (1.4 × 106 cpm/pmol) by incubation at 30 °C for 20 min in a
solution (40 µl) containing 18 mM Tris/HCl at pH 7.5, 8.1 mM EDTA, 0.9 mM DTT, 4.5 mM
MgCl2, and 0.3% CHAPS. After this incubation, 4 µl of
100 mM MgCl2 was added to give a final
concentration of 13 mM, and the mixture was immediately
cooled on ice. Where indicated, [35S]GDP
S (1.4 × 106 cpm/pmol) was used instead of
[35S]GTP
S. The sample to be tested was subjected to
SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was
blocked at 4 °C in PBS containing 5 mM DTT, 50 mM ZnCl2, 0.1% Triton X-100, and 1 mg/ml BSA.
The membrane was then incubated at room temperature for 5 min, followed
by incubation at 4 °C for 10 min with 5 nM [35S]GTP
S-GST-Rab11 (7.0 × 106 cpm)
in a solution (1 ml) containing 25 mM MES/NaOH at pH 6.5, 2.5 mM DTT, 50 mM NaCl, 1.25 mM
MgCl2, and 1.25 mg/ml BSA. Where indicated, non-radioactive
GTP
S-GST-Rab3A, -Rab5, or -RhoA (650 pmol each) was added to this
solution. After the incubation, the membrane was washed with
25 mM MES/NaOH at pH 6.5 containing 50 mM NaCl,
5 mM MgCl2, and 0.05% Triton X-100, followed
by autoradiography by use of an image analyzer (Fujix BAS-2000; Fuji
Photo Film Co., Tokyo, Japan).
80 °C until use. One-eighth of the
supernatant (40 ml, 320 mg of protein) was applied on a Mono Q HR 10/10
column (Amersham Pharmacia Biotech) equilibrated with Buffer A (20 mM Tris/HCl at pH 7.5, 1 mM EDTA, 1 mM DTT, and 5 mM MgCl2). Elution
was performed with a 240-ml linear gradient of NaCl (0-1
M) in Buffer A. Fractions of 4 ml each were collected.
Rabphilin-11 appeared in fractions 16-18. The active fractions (12 ml,
10 mg of protein) were collected. The rest of the supernatant fraction
was also subjected to the Mono Q column chromatography in the same
manner as described above. The active fractions of the eight Mono Q
column chromatographies were combined. Half of the combined sample (48 ml, 40 mg of protein) was applied on a hydroxyapatite column (1.0 × 10 cm; Calbiochem) equilibrated with Buffer B (20 mM
potassium phosphate at pH 7.5 and 1 mM DTT). Elution was
performed with a 120-ml linear gradient of potassium phosphate (20-500
mM) in Buffer B. Fractions of 2 ml each were collected.
Rabphilin-11 appeared in fractions 10-16. The active fractions (14 ml,
2 mg of protein) were collected. The other half of the combined sample
of the Mono Q column chromatographies was also subjected to the
hydroxyapatite column chromatography in the same manner as described
above. The active fractions (28 ml, 4 mg of protein) of the two
hydroxyapatite column chromatographies were combined and applied on a
Mono Q HR 5/5 column equilibrated with Buffer A containing 1% cholate.
Elution was performed with a 15-ml linear gradient of NaCl (0-1
M) in Buffer A containing 1% cholate. Fractions of 0.5 ml
each were collected. Rabphilin-11 appeared in fractions 12-20. The
active fractions (4.5 ml, 2 mg of protein) were collected and applied
on a TSK gel phenyl-5PW RP column (0.75 × 7.5 cm; Tosoh, Tokyo,
Japan) equilibrated with 0.08% trifluoroacetic acid. Elution was
performed with a 60-ml linear gradient of acetonitrile (0-80%) in
0.08% trifluoroacetic acid. Fractions of 0.5 ml each were collected.
Rabphilin-11 appeared in fractions 78-83 (see Fig. 1). The active
fractions (3 ml, 0.3 mg of protein) were collected and lyophilized.
This lyophilized sample (0.3 mg of protein) was dissolved in 0.3 ml of
Laemmli's buffer and subjected to SDS-PAGE (8% polyacrylamide gel).
The protein band corresponding to a protein with a
Mr of about 140,000 was cut out from the gel and
digested with a lysyl endopeptidase, and the digested peptides were
separated by TSKgel PODS-80Ts (4.6 × 150 mm; Tosoh) reverse phase
high pressure liquid column chromatography (22). The aa sequences of
the 13 peptides were determined with a peptide sequencer. A rat brain
cDNA library in
ZAPII (Stratagene) was screened by use of the
oligonucleotide probes designed from the partial aa sequences.
-Myc-Rab11Q70L in HeLa cells (sHeLa-Myc-Rab11Q70L
cells) was carried out by use of Superfect reagent (Qiagen), and cell
clones were isolated by resistance to G418 as described previously
(23). sMDCK cells were maintained at 37 °C in a humidified
atmosphere of 10% CO2 and 90% air in DMEM containing 10%
FCS (Life Technologies, Inc.), 100 units/ml penicillin, 100 µg/ml
streptomycin, and 0.75 mg/ml G418. sHeLa cells were maintained at
37 °C in a humidified atmosphere of 5% CO2 and 95% air
in the same medium.
antibody was purchased from Sigma. Second antibodies for
immunofluorescence microscopy were obtained from Chemicon
International, Inc. Temecula, CA).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S-GST-Rab11-binding activity with a
Mr of about 140,000 in the cytosol fraction of
bovine brain by use of a blot overlay method with
[35S]GTP
S-GST-Rab11 (data not shown). We highly
purified this protein (p140) from the cytosol fraction of bovine brain
by successive chromatographies of Mono Q, hydroxyapatite, Mono Q, and
phenyl-5PW RP columns as described under "Experimental Procedures."
On the final phenyl-5PW RP column chromatography, the
[35S]GTP
S-GST-Rab11-binding protein band coincided
with a protein with a Mr of about 140,000 which
was identified by protein staining (Fig.
1, A
C). p140 bound
[35S]GTP
S-GST-Rab11 more preferentially than
[35S]GDP
S-GST-Rab11 (Fig.
2Aa). p140 did not stimulate
the GTPase activity of Rab11 (data not shown). p140 did not bind other
Rab and Rho small G proteins, including Rab3A, Rab5, and RhoA (Fig. 2Ba).

View larger version (50K):
[in a new window]
Fig. 1.
Phenyl-5PW RP column chromatography of p140
(rabphilin-11). A, absorbance at 280 nm. B,
[35S]GTP
S-GST-Rab11 blot overlay. An aliquot (20 µl)
of each fraction was subjected to SDS-PAGE, followed by
[35S]GTP
S-GST-Rab11 blot overlay. C,
protein staining with Coomassie Brilliant Blue. An aliquot (20 µl) of
each fraction was subjected to SDS-PAGE, followed by protein staining
with Coomassie Brilliant Blue. Arrowheads, p140
(rabphilin-11).

View larger version (38K):
[in a new window]
Fig. 2.
Biochemical properties of rabphilin-11.
A, binding of [35S]GTP
S-GST-Rab11 to
rabphilin-11. The rat brain cytosol (50 µg of protein) or
MBP-rabphilin-11-1 (aa 1-631) (0.2 µg of protein) was subjected to
SDS-PAGE, followed by [35S]GTP
S- or
[35S]GDP
S-GST-Rab11 blot overlay. a, the
rat brain cytosol; b, MBP-rabphilin-11-1. Lane
1, [35S]GTP
S-GST-Rab11 blot overlay; lane
2, [35S]GDP
S-GST-Rab11 blot overlay.
Arrowhead, MBP-rabphilin-11-1. Lower molecular mass bands
seen in A, b, lane 1, may be
degradation products of rabphilin-11. B, small G protein
specificity of rabphilin-11. The rat brain cytosol (50 µg of protein)
or MBP-rabphilin-11-1 (0.2 µg of protein) was subjected to SDS-PAGE,
followed by [35S]GTP
S-GST-Rab11 blot overlay in the
presence of 0.65 µM various nonradioactive small G
proteins (130-fold higher concentration than that of
[35S]GTP
S-GST-Rab11). a, the rat brain
cytosol; b, MBP-rabphilin-11-1. Lane 1,
[35S]GTP
S-GST-Rab11 alone; lane 2, in the
presence of nonradioactive GTP
S-GST-Rab11; lane 3, in the
presence of nonradioactive GTP
S-GST-Rab3A; lane 4, in the
presence of nonradioactive GTP
S-GST-Rab5; lane 5, in the
presence of nonradioactive GTP
S-GST-RhoA.

View larger version (64K):
[in a new window]
Fig. 3.
Molecular characterization of
rabphilin-11. A, deduced aa sequence of rabphilin-11.
Underlines, aa sequences of the 13 peptide peaks derived
from the purified sample of p140 (rabphilin-11). B, a, [35S]GTP
S-GST-Rab11 binding activity of
the native and recombinant proteins of rabphilin-11. The rat brain
cytosol (50 µg of protein) or the in vitro translated
product of rabphilin-11 was subjected to SDS-PAGE, followed by
[35S]GTP
S-GST-Rab11 blot overlay. Lane 1,
the rat brain cytosol; lane 2, the in vitro
translated product. b, [35S]GTP
S-GST-Rab11
binding activity of truncated forms of rabphilin-11.
MBP-rabphilin-11-1 (aa 1-631) or MBP-rabphilin-11-2 (aa 632-908)
(0.5 µg of protein each) was subjected to SDS-PAGE, followed by
[35S]GTP
S-GST-Rab11 blot overlay. Lane 1,
MBP-rabphilin-11-1; lane 2, MBP-rabphilin-11-2.
Arrowhead, MBP-rabphilin-11-1. Lower molecular mass bands
seen in B, b, lane 1, may be
degradation products of rabphilin-11.
S-GST-Rab11 binding activity was located in
the N-terminal fragment (aa 1-631) and not in the C-terminal fragment
(aa 632-908) (Fig. 3Bb). This N-terminal fragment,
including the GTP-Rab11 binding domain, bound
[35S]GTP
S-GST-Rab11 more preferentially than
[35S]GDP
S-GST-Rab11 (Fig. 2Ab). The
N-terminal fragment did not stimulate the GTPase activity of Rab11
(data not shown). The N-terminal fragment did not bind other Rab and
Rho small G proteins, including Rab3A, Rab5, and RhoA (Fig.
2Bb).

View larger version (98K):
[in a new window]
Fig. 4.
Northern blot analysis of rabphilin-11.
An RNA blot membrane (CLONTECH, Palo Alto, CA) was
hybridized with the 32P-labeled, 1.2-kilobase pair
(kb) fragment of the rabphilin-11 cDNA according to the
manufacturer's protocol. Lane 1, heart; lane 2,
brain; lane 3, spleen; lane 4, lung; lane
5, liver; lane 6, muscle; lane 7,
kidney.

View larger version (142K):
[in a new window]
Fig. 5.
Colocalization of GTP-Rab11 and rabphilin-11
at perinuclear regions in MDCK cells. sMDCK-Myc-Rab11Q70L and
-Myc-Rab11S25N cells transiently expressing GFP-tagged full-length
rabphilin-11 were stained with the anti-Myc antibody. The cells were
examined for GFP fluorescence for rabphilin-11 and indirect
immunofluorescence labeling for the Myc-tagged proteins by use of an
LSM 410 confocal laser scanning microscope. A, a,
Myc-Rab11-S25N; b, GFP-rabphilin-11. B, a, Myc-Rab11Q70L; b, GFP-rabphilin-11.
Bars, 20 µm.

View larger version (35K):
[in a new window]
Fig. 6.
Colocalization of GTP-Rab11 and rabphilin-11
along microtubules in HeLa cells. A, colocalization of
Rab11Q70L and rabphilin-11 along microtubules. Wild-type HeLa cells and
sHeLa-Myc-Rab11Q70L cells were cultured on fibronectin and doubly
stained by use of the anti-Myc antibody for Myc-Rab11Q70L, the
anti-rabphilin-11 antibody for rabphilin-11, and the anti-tubulin
antibody for microtubules. a1-c1 and a3-c3,
sHeLa-Myc-Rab11Q70L cells; a2-c2, wild-type HeLa cells.
a1 and a3, Myc-Rab11Q70L; a2 and
b3, rabphilin-11; b1 and
b2, microtubules; c1-c3, merge.
B, localization of the N-terminal fragment of rabphilin-11
along microtubules. HeLa cells transiently transfected with the plasmid
encoding GFP-rabphilin-11-1 (aa 1-631) or GFP-rabphilin-11-4 (aa
607-730) were examined for GFP fluorescence for rabphilin-11.
a, the GFP-tagged N-terminal fragment of rabphilin-11 (aa
1-631); b, the GFP-tagged C-terminal fragment of
rabphilin-11 (aa 607-730). C, disruption of microtubules
and dispersion of Rab11Q70L and rabphilin-11 by treatment with
nocodazole. sHeLa-Myc-Rab11Q70L cells and wild-type HeLa cells cultured
on fibronectin were treated with 10 µg/ml nocodazole for 1 h.
a1 and b1, sHeLa-Myc-Rab11Q70L cells;
a2 and b2, wild-type HeLa cells. a1,
Myc-Rab11Q70L; a2, rabphilin-11; b1 and
b2, microtubules. Bars, 20 µm.

View larger version (56K):
[in a new window]
Fig. 7.
Involvement of rabphilin-11 in
internalization of transferrin. HeLa cells or KB cells, which were
transiently transfected with the plasmids encoding the indicated
proteins, were incubated with Texas Red-conjugated transferrin. The
cells were examined for GFP fluorescence for rabphilin-11 and Texas Red
fluorescence for transferrin. A, HeLa cells; B,
KB cells. a and c, Texas Red-conjugated
transferrin; b, the GFP-tagged C-terminal fragment of
rabphilin-11 (aa 607-730); d, GFP-rabphilin-11.
Arrows, the cells expressing the indicated proteins.
Bars, 20 µm.

View larger version (51K):
[in a new window]
Fig. 8.
Involvement of rabphilin-11 in cell
migration. HeLa cells, which were transiently transfected with the
plasmid encoding GFP-tagged full-length rabphilin-11,
GFP-rabphilin-11-1 (aa 1-631), or GFP-rabphilin-11-4 (aa 607-730),
were incubated on gold- and fibronectin-coated coverslips. The
transfected cells were examined for GFP fluorescence, and cell
migration was analyzed by phase-contrast microscopy as the area free of
gold particles around a single cell per 6 h. A,
migration of HeLa cells. a1-c1, GFP fluorescence;
a2-c2, HeLa cells. Arrows, the cells expressing
the indicated proteins. Arrowheads, wild-type HeLa cells.
B, the area of the motile cells. a,
GFP-rabphilin-11; b, the GFP-tagged N-terminal fragment of
rabphilin-11 (aa 1-631); c, the GFP-tagged C-terminal
fragment of rabphilin-11 (aa 607-730). The area was expressed as mean
± S.D. (*, p < 0.01). All the photographs
were taken with the same magnification.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
FOOTNOTES |
|---|
* This investigation was supported by grants-in-aid for Scientific Research and for Cancer Research from the Ministry of Education, Science, Sports, and Culture, Japan (1998) and by grants from the Human Frontier Science Program (1998).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF130121.
To whom correspondence should be addressed: Dept. of Molecular
Biology and Biochemistry, Osaka University Medical School, Suita
565-0871, Japan. Tel.: 81-6-6879-3410; Fax: 81-6-6879-3419; E-mail:
ytakai@molbio.med.osaka-u.ac.jp.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
MDCK, Madin-Darby
canine kidney;
GEP, GDP/GTP exchange protein;
GDI, GDP dissociation
inhibitor;
GST, glutathione S-transferase-tagged;
GTP
S, guanosine 5'-(3-O-thio) triphosphate;
DTT, dithiothreitol;
GDP
S, guanosine 5'-(2-O-thio) diphosphate;
PAGE, polyacrylamide gel electrophoresis;
PBS, phosphate-buffered saline;
BSA, bovine serum albumin;
aa, amino acids;
DMEM, Dulbecco's modified
Eagle's medium;
FCS, fetal calf serum;
Myc-Rab11Q70L, a Myc-tagged
dominant active mutant of Rab11;
Myc-Rab11S25N, a Myc-tagged dominant
negative mutant of Rab11;
MBP, maltose-binding protein-tagged;
GFP, green fluorescent protein;
MES, 4-morpholineethanesulfonic acid;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Nuoffer, C., and Balch, W. E. (1994) Annu. Rev. Biochem. 63, 949-990[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Pfeffer, S. R. (1994) Curr. Opin. Cell Biol. 6, 522-526[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Takai, Y., Sasaki, T., Shirataki, H., and Nakanishi, H. (1996) Genes Cells 1, 615-632 [Abstract] |
| 4. | Novick, P., and Zerial, M. (1997) Curr. Opin. Cell Biol. 9, 496-504[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Ohmori, T., Takeyama, Y., Ueda, T., Hiroyoshi, M., Nakanishi, H., Ohyanagi, H., Saitoh, Y., and Takai, Y. (1990) Biochem. Biophys. Res. Commun. 169, 816-823[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Sakurada, K., Uchida, K., Yamaguchi, K., Aisaka, K., Ito, S., Ohmori, T., Takeyama, Y., Ueda, T., Hori, Y., Ohyanagi, H., Saitoh, Y., Kaibuchi, K., and Takai, Y. (1991) Biochem. Biophys. Res. Commun. 177, 1224-1232[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Chavrier, P.,
Vingron, M.,
Sander, C.,
Simons, K.,
and Zerial, M.
(1990)
Mol. Cell. Biol.
10,
6578-6585 |
| 8. | Urbé, S., Huber, L. A., Zerial, M., Tooze, S. A., and Parton, R. G. (1993) FEBS Lett. 334, 175-182[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Ullrich, O.,
Reinsch, S.,
Urbé, S.,
Zerial, M.,
and Parton, R. G.
(1996)
J. Cell Biol.
135,
913-924 |
| 10. |
Chen, W.,
Feng, Y.,
Chen, D.,
and Wandinger-Ness, A.
(1998)
Mol. Biol. Cell
9,
3241-3257 |
| 11. |
Ren, M.,
Xu, G.,
Zeng, J.,
De Lemos-Chiarandini, C.,
Adesnik, M.,
and Sabatini, D. D.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6187-6192 |
| 12. |
Shirataki, H.,
Kaibuchi, K.,
Yamaguchi, T.,
Wada, K.,
Horiuchi, H.,
and Takai, Y.
(1992)
J. Biol. Chem.
267,
10946-10949 |
| 13. |
Shirataki, H.,
Kaibuchi, K.,
Sakoda, T.,
Kishida, S.,
Yamaguchi, T.,
Wada, K.,
Miyazaki, M.,
and Takai, Y.
(1993)
Mol. Cell. Biol.
13,
2061-2068 |
| 14. | Wang, Y., Okamoto, M., Schmitz, F., Hofmann, K., and Südhof, T. C. (1997) Nature 388, 593-598[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Stenmark, H., Vitale, G., Ullrich, O., and Zerial, M. (1995) Cell 83, 423-432[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Mu, F. T.,
Callaghan, J. M.,
Steele-Mortimer, O.,
Stenmark, H.,
Parton, R. G.,
Campbell, P. L.,
McCluskey, J.,
Yeo, J. P.,
Tock, E. P.C.,
and Toh, B. H.
(1995)
J. Biol. Chem.
270,
13503-13511 |
| 17. | Simonsen, A., Lippé, R., Christoforidis, S., Gaullier, J. M., Brech, A., Callaghan, J., Toh, B. H., Murphy, C., Zerial, M., and Stenmark, H. (1998) Nature 394, 494-498[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Echard, A.,
Jollivet, F.,
Martinez, O.,
Lacapère, J. J.,
Rousselet, A.,
Janoueix-Lerosey, I.,
and Goud, B.
(1998)
Science
279,
580-585 |
| 19. |
Ren, M.,
Zeng, J.,
De Lemos-Chiarandini, C.,
Rosenfeld, M.,
Adesnik, M.,
and Sabatini, D. D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
5151-5155 |
| 20. |
Diaz, E.,
Schimmoller, F.,
and Pfeffer, S. R.
(1997)
J. Cell Biol.
138,
283-290 |
| 21. |
Manser, E.,
Leung, T.,
Monfries, C.,
Teo, M.,
Hall, C.,
and Lim, L.
(1992)
J. Biol. Chem.
267,
16025-16028 |
| 22. | Imazumi, K., Sasaki, T., Takahashi, K., and Takai, Y. (1994) Biochem. Biophys. Res. Commun. 205, 1409-1416[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Imamura, H.,
Takaishi, K.,
Nakano, K.,
Kodama, A.,
Oishi, H.,
Shiozaki, H.,
Monden, M.,
Sasaki, T.,
and Takai, Y.
(1998)
Mol. Biol. Cell
9,
2561-2575 |
| 24. |
Ohya, T.,
Sasaki, T.,
Kato, M.,
and Takai, Y.
(1998)
J. Biol. Chem.
273,
613-617 |
| 25. | Albrecht-Buehler, G. (1977) Cell 11, 395-404[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Takaishi, K.,
Kikuchi, A.,
Kuroda, S.,
Kotani, K.,
Sasaki, T.,
and Takai, Y.
(1993)
Mol. Cell. Biol.
13,
72-79 |
| 27. | Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Zeng, J.,
Ren, M.,
Gravotta, D.,
De Lemos-Chiarandini, C.,
Lui, M.,
Erdjument-Bromage, H.,
Tempst, P.,
Xu, G.,
Shen, T. H.,
Morimoto, T.,
Adesnik, M.,
and Sabatini, D. D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2840-2845 |
| 30. | Hori, Y., Takeyama, Y., Hiroyoshi, M., Ueda, T., Maeda, A., Ohyanagi, H., Saitoh, Y., Kaibuchi, K., and Takai, Y. (1996) Dig. Dis. Sci. 41, 133-138[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Waterman-Storer, C. M.,
and Salmon, E. D.
(1997)
J. Cell Biol.
139,
417-434 |
| 32. |
Breitfeld, P. P.,
McKinnon, W. C.,
and Mostov, K. E.
(1990)
J. Cell Biol.
111,
2365-2373 |
| 33. |
Apodaca, G.,
Katz, L. A.,
and Mostov, K. E.
(1994)
J. Cell Biol.
125,
67-86 |
| 34. |
Maples, C. J.,
Ruiz, W. G.,
and Apodaca, G.
(1997)
J. Biol. Chem.
272,
6741-6751 |
| 35. | Bretscher, M. S. (1992) EMBO J. 11, 383-389[Medline] [Order article via Infotrieve] |
| 36. |
Hopkins, C. R.,
Gibson, A.,
Shipman, M.,
Strickland, D. K.,
and Trowbridge, I. S.
(1994)
J. Cell Biol.
125,
1265-1274 |
| 37. | Felsenfeld, D. P., Choquet, D., and Sheetz, M. P. (1996) Nature 383, 438-440[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Lawson, M. A., and Maxfield, F. R. (1995) Nature 377, 75-79[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Bretscher, M. S. (1996) Cell 85, 465-467[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Lauffenburger, D. A., and Horwitz, A. F. (1996) Cell 84, 359-369[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Shirataki, H.,
Yamamoto, T.,
Hagi, S.,
Miura, H.,
Oishi, H.,
Jin-no, Y.,
Senbonmatsu, T.,
and Takai, Y.
(1994)
J. Biol. Chem.
269,
32717-32720 |
| 42. | McKiernan, C. J., Stabila, P. F., and Macara, I. G. (1996) Mol. Cell. Biol. 16, 4985-4995[Abstract] |
| 43. | Stahl, B., Chou, J. H., Li, C., Südhof, T. C., and Jahn, R. (1996) EMBO J. 15, 1799-1809[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
A. Masztalerz, I. S. Zeelenberg, Y. M. Wijnands, R. de Bruijn, A. M. Drager, H. Janssen, and E. Roos Synaptotagmin 3 deficiency in T cells impairs recycling of the chemokine receptor CXCR4 and thereby inhibits CXCL12 chemokine-induced migration J. Cell Sci., January 15, 2007; 120(2): 219 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Prigozhina and C. M. Waterman-Storer Decreased polarity and increased random motility in PtK1 epithelial cells correlate with inhibition of endosomal recycling. J. Cell Sci., September 1, 2006; 119(Pt 17): 3571 - 3582. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Ducharme, C. M. Hales, L. A. Lapierre, A.-J. L. Ham, A. Oztan, G. Apodaca, and J. R. Goldenring MARK2/EMK1/Par-1B{alpha} Phosphorylation of Rab11-Family Interacting Protein 2 Is Necessary for the Timely Establishment of Polarity in Madin-Darby Canine Kidney Cells Mol. Biol. Cell, August 1, 2006; 17(8): 3625 - 3637. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Pooley, S. Reddy, V. Soukoulis, J. T. Roland, J. R. Goldenring, and D. M. Bader CytLEK1 Is a Regulator of Plasma Membrane Recycling through Its Interaction with SNAP-25 Mol. Biol. Cell, July 1, 2006; 17(7): 3176 - 3186. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Naslavsky and S. Caplan C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH? J. Cell Sci., September 15, 2005; 118(18): 4093 - 4101. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Hall, E. Smith, W. Langer, L. A. Jacobs, D. Goulding, and M. C. Field Developmental Variation in Rab11-Dependent Trafficking in Trypanosoma brucei Eukaryot. Cell, May 1, 2005; 4(5): 971 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-O. Yoon, S. Shin, and A. M. Mercurio Hypoxia Stimulates Carcinoma Invasion by Stabilizing Microtubules and Promoting the Rab11 Trafficking of the {alpha}6{beta}4 Integrin Cancer Res., April 1, 2005; 65(7): 2761 - 2769. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Colicelli Human RAS Superfamily Proteins and Related GTPases Sci. Signal., September 14, 2004; 2004(250): re13 - re13. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Lindsay and M. W. McCaffrey The C2 domains of the class I Rab11 family of interacting proteins target recycling vesicles to the plasma membrane J. Cell Sci., September 1, 2004; 117(19): 4365 - 4375. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-H. Fan, L. A. Lapierre, J. R. Goldenring, J. Sai, and A. Richmond Rab11-Family Interacting Protein 2 and Myosin Vb Are Required for CXCR2 Recycling and Receptor-mediated Chemotaxis Mol. Biol. Cell, May 1, 2004; 15(5): 2456 - 2469. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Naslavsky, M. Boehm, P. S. Backlund Jr., and S. Caplan Rabenosyn-5 and EHD1 Interact and Sequentially Regulate Protein Recycling to the Plasma Membrane Mol. Biol. Cell, May 1, 2004; 15(5): 2410 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Provance Jr., C. R. Gourley, C. M. Silan, L. C. Cameron, K. M. Shokat, J. R. Goldenring, K. Shah, P. G. Gillespie, and J. A. Mercer From the Cover: Chemical-genetic inhibition of a sensitized mutant myosin Vb demonstrates a role in peripheral-pericentriolar membrane traffic PNAS, February 17, 2004; 101(7): 1868 - 1873. [Abstrac |